3Spuesens EB, Meijer A, Bierschenk D, et al. Macrolide resistance de- termination and molecular typing of mycoplasma pneumoniae in re- spiratory specimens collected between 1997 and 2008 in the Nether- lands [ J ]. Jclin Microbiol,2012,50 ( 6 ) : 1999-2004.
4Momzumi M,Iwata S,Hasegawa K,et al. Increased macmlide resist- ance of Mycoplasma pneumoniae in pediatric patients with communi- ty-acquired pneumonia[ J]. Antimicrob Agents Chemother,2008,52 ( 1 ) :348-350.
6Kawai Y, Miyashita N, Kubo M, et al. Therapeutic efficacy of macrol- ides, minocycline, and tosufloxacin against macrolide-resisrant Myco- plasma pneumoniae pneumonia in pediatric patients [ J ]. Antimicmb Agents Chemother,2013,57(4) :2252-2258.
2Fry AM, Shay DK, Holmah RC, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002[J]. JAMA, 2005, 294(21):2712-2719.
